These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 25509368)

  • 1. Anti glutamate-decarboxylase antibodies: a liaison between localisation related epilepsy, stiff-person syndrome and type-1 diabetes mellitus.
    Szűcs A; Barcs G; Winkler G; Soós Z; Folyovich A; Kelemen A; Várallyay P; Kamondi A
    Ideggyogy Sz; 2014 Jul; 67(7-8):269-71. PubMed ID: 25509368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
    Walikonis JE; Lennon VA
    Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Of stiff men and sweet mice: GAD and diabetes.
    Lancet; 1991 Dec; 338(8780):1428-9. PubMed ID: 1683426
    [No Abstract]   [Full Text] [Related]  

  • 4. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.
    Kono S; Miyajima H; Sugimoto M; Suzuki Y; Takahashi Y; Hishida A
    Intern Med; 2001 Sep; 40(9):968-71. PubMed ID: 11579968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.
    Ali F; Rowley M; Jayakrishnan B; Teuber S; Gershwin ME; Mackay IR
    J Autoimmun; 2011 Sep; 37(2):79-87. PubMed ID: 21680149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff-Man syndrome and insulin-dependent diabetes mellitus.
    Solimena M; De Camilli P
    Trends Neurosci; 1991 Oct; 14(10):452-7. PubMed ID: 1722364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stiff-person syndrome and other neurological disorders associated with anti-GAD antibodies].
    Hijazi J; Bedat-Millet AL; Hannequin D
    Rev Med Interne; 2010 Jan; 31(1):23-8. PubMed ID: 19828214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The $64000 question in diabetes continues.
    Atkinson MA
    Lancet; 2000 Jul; 356(9223):4-6. PubMed ID: 10892753
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.
    Rakocevic G; Raju R; Dalakas MC
    Arch Neurol; 2004 Jun; 61(6):902-4. PubMed ID: 15210528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamic acid decarboxylase autoantibodies and neurological disorders.
    Vianello M; Tavolato B; Giometto B
    Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral autoimmune responses to glutamic acid decarboxylase have similar target epitopes and subclass that show titer-dependent disease association.
    Piquer S; Belloni C; Lampasona V; Bazzigaluppi E; Vianello M; Giometto B; Bosi E; Bottazzo GF; Bonifacio E
    Clin Immunol; 2005 Oct; 117(1):31-5. PubMed ID: 16027042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
    Daw K; Ujihara N; Atkinson M; Powers AC
    J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stiff Person syndrome and other anti-GAD-associated neurologic disorders.
    Dayalu P; Teener JW
    Semin Neurol; 2012 Nov; 32(5):544-9. PubMed ID: 23677666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
    Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
    Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-GAD positive stiff-person syndrome and cerebellar ataxia: two treatable conditions that clinicians should be aware of.
    Ferraz HB
    Arq Neuropsiquiatr; 2012 Sep; 70(9):655-6. PubMed ID: 22990718
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stiff person syndrome--case report].
    Tomczykiewicz K; Pastuszak Z; Staszewski J; Stepień A
    Pol Merkur Lekarski; 2014 Jan; 36(211):28-30. PubMed ID: 24645574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.
    Liimatainen S; Honnorat J; Pittock SJ; McKeon A; Manto M; Radtke JR; ; Hampe CS
    Orphanet J Rare Dis; 2018 Apr; 13(1):55. PubMed ID: 29636076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus.
    Lohmann T; Hawa M; Leslie RD; Lane R; Picard J; Londei M
    Lancet; 2000 Jul; 356(9223):31-5. PubMed ID: 10892762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.